Northstar Capital Management’s Amgen AMGN Stock Holding History

Northstar Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$77K	Hold	400	–	–	0.07%	52
2019 Q2	$74K	Hold	400	–	–	0.07%	51
2019 Q1	$76K	Hold	400	–	–	0.07%	51
2018 Q4	$78K	Hold	400	–	–	0.08%	48
2018 Q3	$83K	Hold	400	–	–	0.07%	51
2018 Q2	$74K	Hold	400	–	–	0.07%	51
2018 Q1	$68K	Hold	400	–	–	0.06%	55
2017 Q4	$70K	Buy	+400	New	+$70.8K	0.07%	57

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northstar Capital Management's AMGN Position: Q3 2019 in Review

Northstar Capital Management held its Amgen (AMGN) position steady in Q3 2019 at 400 shares worth $77K. The position accounts for 0.07% of the portfolio, ranked #52.

Northstar Capital Management first reported a position in AMGN in Q4 2017 and has held it in 8 quarters since. The position peaked at $83K in Q3 2018. 1,884 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

Northstar Capital Management held 400 shares of Amgen worth $77K as of Q3 2019.
Northstar Capital Management left its Amgen share count unchanged in Q3 2019.
Amgen made up 0.07% of Northstar Capital Management's portfolio in Q3 2019, its #52 holding.
Northstar Capital Management first reported a position in Amgen in Q4 2017 and has held it in 8 quarters since.
Northstar Capital Management's Amgen position peaked at $83K in Q3 2018.
1,884 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Northstar Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.